Security key
92673K108
Vigil Neuroscience, Inc. - Common Stock (VIGL)
CUSIP: 92673K108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 33,429,162
- Total 13F value
- $265,762,648
- Share change
- +8,401,154
- SEC-reported price per share
- $7.95
- Number of holders
- 78
- Value change
- +$134,567,195
- Number of buys
- 63
- Number of sells
- 27
- Shares outstanding
- 46,698,729
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
78
Top holders
10
VIGL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Vigil Neuroscience, Inc. SEC filings
Vigil Neuroscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92673K108
Recent filing periods:
Ownership snapshot
Top reported holders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GLAZER CAPITAL, LLC
Disclosed value leader
GLAZER CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 6.4%
13D/G row: GLAZER CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
GLAZER CAPITAL, LLC leads the comparable SEC ownership view at 6.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GLAZER CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
GLAZER CAPITAL, LLC
6.4%
Invus Global Management, LLC
4.9%
Vida Ventures GP III, L.L.C.
3.5%
Atlas Venture Life Science Adviso...
12%
BVF INC/IL
8.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC |
13D/G
|
6.4%
|
$24,247,147
3,012,068 shares
|
+$4,013,778 | 30 Jun 2025 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
4.9%
|
$3,563,958
1,991,038 shares
|
$0 | 31 Dec 2024 |
| Vida Ventures GP III, L.L.C. |
3/4/5
13D/G
10%+ Owner
|
3.5%
from 13D/G
|
$18,809,734
5,015,929 shares
|
— | 11 Jan 2022 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
12%
|
$10,389,636
5,836,874 shares
|
— | 31 Mar 2025 |
| BVF INC/IL |
13F
Company
|
8.6%
|
$7,144,267
4,013,633 shares
|
— | 31 Mar 2025 |
| Siren, L.L.C. |
13F
Individual
|
4.2%
|
$3,501,374
1,967,064 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
33,429,162
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2025 holders
78
Holder diff
77
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend